EPIRUBICIN HYDROCHLORIDE (EPIRUBICIN HYDROCHLORIDE) — FDA Approval ANDA065411 (FRESENIUS KABI USA)
EPIRUBICIN HYDROCHLORIDE (EPIRUBICIN HYDROCHLORIDE) — FDA Approval ANDA065411 (FRESENIUS KABI USA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: EPIRUBICIN HYDROCHLORIDE; Active ingredients: EPIRUBICIN HYDROCHLORIDE; Application number: ANDA065411.
| Brand name | EPIRUBICIN HYDROCHLORIDE |
|---|---|
| Active ingredients | EPIRUBICIN HYDROCHLORIDE |
| Application number | ANDA065411 |
| Sponsor | FRESENIUS KABI USA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20070820 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →